Amgen Inc. Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
Merck & Co. Inc. Novartis AG
Pfizer Inc. Radius Health Inc. Teva Pharmaceutical Industries Ltd. and UCB S.A.
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 149 | iMarc Group | ASDR-639962 |
Amgen Inc. Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
Merck & Co. Inc. Novartis AG
Pfizer Inc. Radius Health Inc. Teva Pharmaceutical Industries Ltd. and UCB S.A.